Product News
ChemPartner’s bispecific ADC platform accelerates oncology drug discovery
The comprehensive preclinical screening platform was validated using HER2 x TROP2 bsADC as a proof of concept
The comprehensive preclinical screening platform was validated using HER2 x TROP2 bsADC as a proof of concept